Concepedia

Short-Term Topical Bevacizumab in the Treatment of Stable Corneal Neovascularization

Sheng-Fu Cheng, Mohammad H. Dastjerdi, Giulio Ferrari, Andre Okanobo, Kraig S. Bower, Denise S. Ryan, Francisco Amparo, William Stevenson, Pedram Hamrah, Nambi Nallasamy,

American Journal of Ophthalmology · 2012 · 56 citations · 23 references

DOIFull text

Open access

Concepts

References

23

Global data on visual impairment in the year 2002.

Serge Resnikoff, Donatella Pascolini, Daniel Etya’ale et al. · PubMed · 2004 · 4.2K citations

, , +16

The <i>fms</i> -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor

Carlie de Vries, Jaime A. Escobedo, Hikaru Ueno et al. · Science · 1992 · 2K citations

, , +14

Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration

Robert L. Avery, Dante J. Pieramici, Melvin Rabena et al. · Ophthalmology · 2006 · 1.1K citations

, , +14

Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy

Robert L. Avery, Joel Pearlman, Dante J. Pieramici et al. · Ophthalmology · 2006 · 802 citations

, , +13

Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium.

Timothy P. Quinn, Kevin G. Peters, C. de Vries et al. · Proceedings of the National Academy of Sciences · 1993 · 760 citations

, , +16